No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab treatment does not show added activity in chronic lymphocytic leukaemia

byKathleen Lau

March 24, 2022

in StudyGraphics

Reading Time: 1 min read

Rates of recurrent ischemic stroke among young adults with prior embolic stroke of undetermined source– the Young ESUS longitudinal cohort study

RelatedReports

Multidrug induction therapy increases remission from lupus nephritis

Chronic Disease

Obinutuzumab plus standard therapy is efficacious in managing active lupus nephritis

May 21, 2025

StudyGraphics

#VisualAbstract: Obinutuzumab Plus Standard Therapy Provided Complete Renal Response in Active Lupus Nephritis

February 21, 2025

Phase III trial shows survival benefit for early multiple myeloma

Oncology

Minimal Residual Disease negativity after Autologous Hematopoietic Cell Transplantation with lenalidomide maintenance predicts better long-term outcomes in myeloma

May 13, 2024

Combined lenalidomide and rituximab dose escalation found to be safe for CLL

Chronic Disease

Venetoclax monotherapy effectively treats relapsed or refractory chronic lymphocytic leukemia

March 25, 2024

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Hospitalized Covid-19 patients from socially vulnerable neighborhoods have greater illness severity

Parental nonmedical prescription opioid use linked to adolescent use

2 Minute Medicine Rewind Mar 21, 2022

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

Percutaneous transforaminal endoscopic discectomy non-inferior to open microdisctectomy

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports